Core Laboratories N.V is an oil & gas equipment & services business based in the US. Core Laboratories N-V shares (CLB) are listed on the NYSE and all prices are listed in US Dollars. Core Laboratories N-V employs 3,700 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Core Laboratories N-V
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CLB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- CLB shares summary
- Compare share dealing platforms
- Is CLB stock a buy or sell?
- Stock performance over time
- Can I short CLB shares?
- Are CLB shares over-valued?
- Core Laboratories N-V's financials
- How volatile are CLB shares?
- Does Core Laboratories N-V pay a dividend?
- Have CLB shares ever split?
- Other common questions
Core Laboratories N-V stock price (NYSE: CLB)Use our graph to track the performance of CLB stocks over time.
Core Laboratories N-V shares at a glance
|Latest market close||$41.80|
|52-week range||$13.42 - $49.87|
|50-day moving average||$38.45|
|200-day moving average||$35.27|
|Wall St. target price||$33.40|
|Dividend yield||$0.04 (0.12%)|
|Earnings per share (TTM)||$0.42|
Buy Core Laboratories N-V shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Core Laboratories N-V stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Core Laboratories N-V price performance over time
|1 week (2021-07-24)||N/A|
|1 month (2021-07-02)||7.84%|
|3 months (2021-05-04)||42.32%|
|6 months (2021-01-31)||N/A|
|1 year (2020-07-31)||N/A|
|2 years (2019-07-31)||N/A|
|3 years (2018-07-31)||N/A|
|5 years (2016-07-31)||N/A|
Is Core Laboratories N-V under- or over-valued?
Valuing Core Laboratories N-V stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Core Laboratories N-V's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Core Laboratories N-V's P/E ratio
Core Laboratories N-V's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 79x. In other words, Core Laboratories N-V shares trade at around 79x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Core Laboratories N-V's PEG ratio
Core Laboratories N-V's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0984. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Core Laboratories N-V's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Core Laboratories N-V's EBITDA
Core Laboratories N-V's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $67.3 million.
The EBITDA is a measure of a Core Laboratories N-V's overall financial performance and is widely used to measure a its profitability.
Core Laboratories N-V financials
|Revenue TTM||$443.2 million|
|Operating margin TTM||10.61%|
|Gross profit TTM||$102.1 million|
|Return on assets TTM||4.77%|
|Return on equity TTM||18.02%|
|Market capitalisation||$1.5 billion|
TTM: trailing 12 months
Shorting Core Laboratories N-V shares
There are currently 3.9 million Core Laboratories N-V shares held short by investors – that's known as Core Laboratories N-V's "short interest". This figure is 22.5% down from 5.0 million last month.
There are a few different ways that this level of interest in shorting Core Laboratories N-V shares can be evaluated.
Core Laboratories N-V's "short interest ratio" (SIR)
Core Laboratories N-V's "short interest ratio" (SIR) is the quantity of Core Laboratories N-V shares currently shorted divided by the average quantity of Core Laboratories N-V shares traded daily (recently around 576738.0952381). Core Laboratories N-V's SIR currently stands at 6.72. In other words for every 100,000 Core Laboratories N-V shares traded daily on the market, roughly 6720 shares are currently held short.
However Core Laboratories N-V's short interest can also be evaluated against the total number of Core Laboratories N-V shares, or, against the total number of tradable Core Laboratories N-V shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Core Laboratories N-V's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 Core Laboratories N-V shares in existence, roughly 80 shares are currently held short) or 0.0841% of the tradable shares (for every 100,000 tradable Core Laboratories N-V shares, roughly 84 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Core Laboratories N-V.
Find out more about how you can short Core Laboratories N-V stock.
Core Laboratories N-V share dividends
Dividend payout ratio: 5.97% of net profits
Recently Core Laboratories N-V has paid out, on average, around 5.97% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.12% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Core Laboratories N-V shareholders could enjoy a 0.12% return on their shares, in the form of dividend payments. In Core Laboratories N-V's case, that would currently equate to about $0.04 per share.
While Core Laboratories N-V's payout ratio might seem low, this can signify that Core Laboratories N-V is investing more in its future growth.
Core Laboratories N-V's most recent dividend payout was on 17 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 29 April 2021 (the "ex-dividend date").
Have Core Laboratories N-V's shares ever split?
Core Laboratories N-V's shares were split on a 2:1 basis on 8 July 2010. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Core Laboratories N-V shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Core Laboratories N-V shares which in turn could have impacted Core Laboratories N-V's share price.
Core Laboratories N-V share price volatility
Over the last 12 months, Core Laboratories N-V's shares have ranged in value from as little as $13.4215 up to $49.8699. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Core Laboratories N-V's is 3.3118. This would suggest that Core Laboratories N-V's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Core Laboratories N-V overview
Core Laboratories N. V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company operates in two segments, Reservoir Description and Production Enhancement. The Reservoir Description segment includes the characterization of petroleum reservoir rock, fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and petroleum products; and proprietary and joint industry studies. The Production Enhancement segment offers services and products relating to reservoir well completions, perforations, stimulations, and production.
Core Laboratories N-V in the news
Core Laboratories (NYSE:CLB) May Have Issues Allocating Its Capital
Core Labs' (CLB) Q2 Earnings and Revenues Miss Estimates
Henry James International Management Inc. Buys Core Laboratories NV, Cemex SAB de CV, Piedmont Lithium Inc, Sells Piedmont Lithium Inc, Baidu Inc, Taiwan Semiconductor Manufacturing Co
Frequently asked questionsWhat percentage of Core Laboratories N-V is owned by insiders or institutions?
Currently 0.189% of Core Laboratories N-V shares are held by insiders and 112.871% by institutions. How many people work for Core Laboratories N-V?
Latest data suggests 3,700 work at Core Laboratories N-V. When does the fiscal year end for Core Laboratories N-V?
Core Laboratories N-V's fiscal year ends in December. Where is Core Laboratories N-V based?
Core Laboratories N-V's address is: Van Heuven Goedhartlaan 7 B, Amstelveen, Netherlands, 1181 LE What is Core Laboratories N-V's ISIN number?
Core Laboratories N-V's international securities identification number is: NL0000200384 What is Core Laboratories N-V's CUSIP number?
Core Laboratories N-V's Committee on Uniform Securities Identification Procedures number is: N22717107
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert